The LDN Book 3: Low Dose Naltrexone. The Latest Research on: Viral Infections, Long COVID, Mold Toxicity, Longevity, Cancer, Depression and More.

By Linda Elsegood

The LDN Book 3, the 3rd in the series following on from the success of Books 1 & 2, includes:
Pharmacology and Best Clinical Practices, Drug-Resistant Depression, Virally Damaged Tissues (including COVID-19, Herpes Simplex (HSV 1 & 2), Varicella-Zoster, Human Parvovirus B19 (B19V), Epstein-Barr (EBV), LDN and Longevity, Mixed Connective Tissue Disease (MCTD), Mold Illness and CIRS, Ophthalmic Conditions, Long COVID, Cancer, and Case Studies, Dosing Protocols with pages of references!

Authors include Pharmacist Stephen Dickson, Dr. Elizabeth Livengood. Dr. Sarah Zielsdorf. Dr. Yusuf M. (JP) Saleeby, Dr. Deanna Windham, Dr. Kent Holtorf, Pharmacist Sebastian Denison. Professor Angus Dalgleish, Dr. Wai Liu, and Dr. Nasha Winters.

Best Seller Author Dr. Pamela W. Smith, MD, MPH, MS said "The great news is that inflammation can be balanced using many modalities from traditional medications to changing eating habits, to adding nutrients and herbal therapies, along with the newest treatment, Low Dose Naltrexone. LDN is a prescription compounded medication that very effectively reduces inflammation.

Low Dose Naltrexone has been shown to be one of the keys to the future of medicine for many disease processes that are inflammatory in nature. It is also an efficacious pain control agent.

It is my hope, and the hope of the world-class authors of this book, that you begin your medical journey toward healing by learning more about this wonderful medication".

• Language: English
• Publisher: Linda Elsegood
• Release date: Oct 4, 2022
• ISBN: 9781739107017

Linda Elsegood

The primary aim of the Trust is to initiate clinical trials of Low Dose Naltrexone for autoimmune diseases and cancers.Whilst working to raise funds for trials, we have helped over 100,000 people obtain LDN from a general practitioner or consultant, either through the National Health Service or by private prescription. We are proud to have helped people not just in the UK but in countries throughout Europe, as well as the USA, Canada, West Indies, Australia, New Zealand, and beyond. On this website and from our downloadable newsletters, you will be able to read the stories of some of these people.We have helped many people with MS, Crohn's, IBS, ME and cancer, to name a few conditions LDN can treat. The use of LDN is spreading.By raising awareness of LDN and funding clinical trials that will be published for the benefit of the public, we hope to achieve our ultimate goal for everyone to be prescribed LDN by the NHS and around the world, for all conditions where LDN could be of benefit. The LDN Research Trust is a non-profit Registered Charity, and everyone is a volunteer. Only expenses for the running of the charity will be taken, and these will be at cost.To help us continue our work to bring relief to all people with multiple sclerosis and other conditions, we would appreciate help with fundraising, either in cash or in kind. You can be sure that all contributions are greatly appreciated, however small